OpenAI stated: “We’re introducing ChatGPT for Clinicians, a version of ChatGPT designed to support clinical tasks like documentation and medical research so clinicians can focus on delivering high-quality patient care. We’re making it free for any verified physician, NP, PA, or pharmacist, starting in the U.S.” Shares of Doximity (DOCS) are down 1% to $24.02 in pre-market trading following the announcement.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Qorvo downgraded, Ulta Beauty upgraded: Wall Street’s top analyst calls
- Morning Movers: Energy stocks higher amid U.S.-Iran tensions
- Truist downgrades Doximity on weakening revenue growth visibility
- Doximity downgraded to Hold from Buy at Truist
- Doximity announces resignation of CFO Anna Bryson, reaffirms Q4, FY guidance
